Biosplice Therapeutics
0 followers
About Biosplice Therapeutics
Biosplice Therapeutics is a biotechnology company focused on therapeutic modulation of alternative splicing by targeting CLK and DYRK family kinases. The company aims to develop first-in-class therapies that influence tissue-specific RNA splice-site selection to treat disease. Its clinical development programs address osteoarthritis, oncology, neurology, and diabetes, reflecting a focus on diseases driven by splicing dysregulation. Headquartered in the biotech ecosystem, Biosplice advances research into splicing biology to create targeted, disease-modifying treatments.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.